The SYNBioSe Study A proof-of-concept study involving synergetic B-cell imunnomodulation in patients with refractory systemic lupus erythematosus
Phase of Trial: Phase II
Latest Information Update: 03 Jul 2017
At a glance
- Drugs Belimumab (Primary) ; Rituximab (Primary)
- Indications Systemic lupus erythematosus
- Focus Proof of concept; Therapeutic Use
- Acronyms Synbiose
- 03 Jul 2017 New trial record
- 17 Jun 2017 Results (n=11) presented at the 18th Annual Congress of the European League Against Rheumatism.
- 17 Jun 2017 Results (n=10) presented at the 18th Annual Congress of the European League Against Rheumatism.